Background The proteins S100B, neuron-specific enolase (NSE), glial fibrillary acidic
protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and neurofilament light …

Accurate diagnosis for mild traumatic brain injury (mTBI) remains challenging, as prognosis
and return-to-play/work decisions are based largely on patient reports. Numerous …

Brain-enriched protein biomarkers of tissue fate are being introduced clinically to aid in
traumatic brain injury (TBI) management. The aim of this study was to determine how …

Objective To evaluate serum neuronal and inflammatory biomarkers to determine whether
measurements of umbilical cords at birth can stratify severity of hypoxic-ischemic …

The role of systemic autoimmunity in human traumatic brain injury (TBI) and other forms of
brain injuries is recognized but not well understood. In this study, a systematic investigation …

Huntington's Disease (HD) is a devastating neurodegenerative disorder that is caused by an
expanded CAG trinucleotide repeat in the Huntingtin (HTT) gene. Transcriptional …

Objective: The biomarkers glial fibrillary acid protein (GFAP) and S100B are increasingly
used as prognostic tools in severe traumatic brain injury (TBI). Data for mild TBI are scarce …

Study design This is a narrative review of the literature on neurochemical biomarkers in
spinal cord injury (SCI). Objectives The objective was to summarize the literature on …

Background: Serum glial fibrillary acidic protein (GFAP) is a specific predictor of brain
damage and neurologic outcome in patients with traumatic brain injury (TBI). In this study …

Traumatic brain injury is a major health and socioeconomic problem that affects all societies.
However, traditional approaches to the classification of clinical severity are the subject of …